# Immune Profiling of COVID19-patients Admitted to ICU

> **NCT04473131** · — · UNKNOWN · sponsor: **Hamad Medical Corporation** · enrollment: 300 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT04473131
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-27
- **Primary completion:** 2022-06
- **Final completion:** 2022-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-07-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04473131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04473131, "Immune Profiling of COVID19-patients Admitted to ICU". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04473131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*